Rigel Pharmaceuticals Inc...

NASDAQ: RIGL · Real-Time Price · USD
40.08
0.57 (1.44%)
At close: Aug 18, 2025, 3:59 PM
41.20
2.81%
After-hours: Aug 18, 2025, 07:42 PM EDT

Rigel Pharmaceuticals Revenue

Rigel Pharmaceuticals reported an annual revenue of $179.28M, reflecting a 53.38% growth. For the quarter ending June 30, 2025, Rigel Pharmaceuticals generated $101.69M in revenue.
Revenue (ttm)
179.28M
Revenue Growth
53.38%
Price / Sales Ratio
1.65
Revenue / Employee
1.11M
Employees
162
Market Cap
718.84M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 179.28M +53.38%
Dec 31, 2023 116.88M -2.79%
Dec 31, 2022 120.24M -19.43%
Dec 31, 2021 149.24M +37.39%
Dec 31, 2020 108.62M +83.21%
Dec 31, 2019 59.29M +33.20%
Dec 31, 2018 44.51M +892.62%
Dec 31, 2017 4.48M -78.00%
Dec 31, 2016 20.38M -29.46%
Dec 31, 2015 28.89M +250.24%
Dec 31, 2014 8.25M +15.38%
Dec 31, 2013 7.15M +217.78%
Dec 31, 2012 2.25M -52.63%
Dec 31, 2011 4.75M -96.20%
Dec 31, 2010 125M +16566.67%
Dec 31, 2009 750K +Infinity%
Dec 31, 2008 0 -100.00%
Dec 31, 2007 12.6M -62.36%
Dec 31, 2006 33.47M +102.55%
Dec 31, 2005 16.53M +249.17%
Dec 31, 2004 4.73M -57.19%
Dec 31, 2003 11.05M -29.98%
Dec 31, 2002 15.79M +3.17%
Dec 31, 2001 15.3M +15.77%
Dec 31, 2000 13.22M +47.13%
Dec 31, 1999 8.98M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.